semaglutide subcutaneous or intramuscular Practice Nurse Spotlight on the Mechanism of

Seiwerth S., Milavic M., Vukojevic J., et al

The results showed that, compared with placebo, avexitide 30 mg twice daily (BID) and 60 mg once daily (QD) significantly increased mean plasma glucose nadir (prespecified primary endpoint) and lowered insulin peak, corresponding to 50% and 75% fewer participants requiring rescue during mixed meal tolerance testing, respectively

Mesleh, A.G., et al

doi:10.1152/ajpendo.00201.2006 U.S

Even moving just two inches from your last injection site makes a meaningful difference

Additionally, semaglutides effectiveness is optimized when taken in conjunction with a healthy diet and regular exercise program